步态特征的相互作用和担心在社区居住的老年人中跌倒的担忧
Sabine Britting1, Sebastian Krumpoch1, Ulrich Lindemann2
1Department of Internal Medicine-Geriatrics, Institute for Biomedicine of Aging, Friedrich-Alexander-Universität Erlangen-Nürnberg, Kobergerstr. 60, 90408, Nürnberg, Germany.
Scientific reports
|December 12, 2025
概括
在老年人中,对跌倒 (CaF) 的担忧与谨慎的步行有关. 步行速度和动态平衡的测量显著预测CaF,这表明潜在的查工具在社区居住的老年人谨慎步行.
科学领域:
- 老年学是指老年学的学科.
- 生物力学 生物力学
- 公共卫生 公共卫生
背景情况:
- 对跌倒 (CaF) 的担忧在老年人中很普遍,往往导致跌倒发生率增加.
- 谨慎步行被认为是与CaF相关的步行模式,但具体的步行参数仍然不清楚.
研究的目的:
- 调查特定步行特征与社区老年人的CaF之间的关联.
- 确定与CaF最强烈相关的步行参数,并探索对谨慎步行的潜在查工具.
主要方法:
- 从FEARFALL和MOGA研究中对261名社区老年人 (65岁以上) 的数据进行横截面分析.
- 使用仪器行走道进行步行分析,并使用国际布效率量表 (FES-I) 评估CaF.
- 多个阶段回归模型用于确定步态参数,FES-I分数和单个FES-I项目之间的关联.
主要成果:
- 较高的FES-I得分与各种步行参数的较差步行表现显著相关.
- 正常的步行速度解释了FES-I变异的24.9%,增加到最大步行速度和步行比率的29.2%.
- 与动态平衡相关的四个FES-I项目显示了对谨慎步行进行查的潜力 (调整R2 = .201).
结论:
- 步行变量,特别是步行速度,与老年人的CaF有很强的关联.
- 评估动态平衡的特定FES-I项目可以作为有效的选工具,用于识别谨慎的步行模式.
更多相关视频
07:27Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty
Published on: October 6, 2016
10.6K
04:13Using a Real-Time Locating System to Measure Walking Activity Associated with Wandering Behaviors Among Institutionalized Older Adults
Published on: February 8, 2019
7.2K
相关概念视频
Drug Dosing: Geriatric Patients
209
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
209
Pharmacodynamics in Geriatric Patients: Effects of Age
175
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
175
